Qube Research & Technologies (QRT)’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.15M Buy
+381,469
New +$5.28M ﹤0.01% 2081
2025
Q1
– Sell
-50,388
Closed -$173K – 3957
2024
Q4
$173K Buy
+50,388
New +$1.59M ﹤0.01% 2862
2022
Q4
– Sell
-1,940
Closed -$56K – 3079
2022
Q3
$56K Sell
1,940
-277
-12% -$11.3K ﹤0.01% 2114
2022
Q2
$79K Buy
+2,217
New +$75.7K ﹤0.01% 2019

Other funds holding QTTB

Qube Research & Technologies (QRT)'s QTTB Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Q32 Bio (QTTB) in Q3 2026: 381,469 shares worth $3.15M. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in QTTB as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in QTTB in Q2 2022 and has held it in 4 quarters since. 61 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • Qube Research & Technologies (QRT) held 381,469 shares of Q32 Bio worth $3.15M as of Q3 2026.
  • Q32 Bio was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Q32 Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2081 holding.
  • Qube Research & Technologies (QRT) first reported a position in Q32 Bio in Q2 2022 and has held it in 4 quarters since.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.